Search

Your search keyword '"Szto G"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Szto G" Remove constraint Author: "Szto G"
24 results on '"Szto G"'

Search Results

2. Edoxaban versus warfarin in patients with atrial fibrillation

3. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

4. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

5. Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48

6. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

7. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

8. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

9. Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

10. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

11. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents

12. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents

17. The Impact of Diabetes Mellitus on Early and Late Mortality and Major Adverse Cardiac Events after Percutaneous Coronary Intervention with Drug-Eluting Stents

18. Impact of Congestive Cardiac Failure on Outcomes after Percutaneous Coronary Interventions: An Analysis of the Melbourne Interventional Group (MIG) Registry

20. Fatal neutropenia and thrombocytopenia associated with ticlopidine after stenting.

21. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.

22. Use of drug-eluting stents in Victorian public hospitals.

23. Percutaneous transluminal coronary angioplasty and stenting for cocaine-induced acute myocardial infarction: a case report and review.

24. Alfred Hospital Coronary Care Unit: an acute myocardial infarction quality assurance study.

Catalog

Books, media, physical & digital resources